ICON PLC (NASDAQ:ICLR)
| 33.43 Data as of May 23 |  +0.29 / +0.88%Today’s Change | 20.25 Today|||52-Week Range 35.86 | +20.43% Year-to-Date |
Latest ICLR News | Press Releases
No recent news for ICON PLC.
Today’s Trading
| Previous close | 33.14 |
| Today’s open | 32.92 |
| Day’s range | -- - -- |
| Volume | 204,210 |
| Average volume (3 months) | 364,067 |
| Market cap | $2.0B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +142.11% |
| Earnings growth (this year) | +57.05% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +17.90% |
| P/E ratio | 34.8 |
| Price/Sales | 1.49 |
| Price/Book | 2.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRLCharles River Labora... | +0.33 | +0.75% |
| ABCOAdvisory Board Co | -0.52 | -1.03% |
| ALNYAlnylam Pharmaceutic... | +0.22 | +0.79% |
| ISISIsis Pharmaceuticals... | +0.25 | +1.23% |
Data as of 4:03pm ET, 05/23/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.38 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $55.4M |
| Net profit margin | 4.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Executive Director Ciaran Murray |
Chief Financial Officer & Head-Investor Relations Brendan Brennan |
Corporate headquarters Dublin, Dublin |
Forecasts
